Back
TAM
Tanami Gold NL
🇦🇺 ASX
⛏️ MINING
👑 Overview
📈 Performance
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
-3.58%
Annual Growth
5 years average annual capital growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
1
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Tanami Gold NL engages in gold mining operations and mineral exploration. The company is headquartered in Perth, Western Australia. The firm has a 50% interest in the Central Tanami Project Joint Venture (CTPJV) located in the Tanami Desert in the Northern Territory. The Central Tanami Project (CTP) is located 650 kilometers northwest of Alice Springs in the Tanami Region of the Northern Territory. The company comprises a series of tenements that collectively cover an area of approximately 2,211 square kilometers (km2) area held in the Tanami Region in the Northern Territory. The tenement holding encompasses prospective, underexplored geological sequences in an area that is known to be well endowed with gold mineralization.
📈 Performance
Price History
+34.15%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🍃 Environmental, Social and Governance scores ℹ️
🌳
Environmental Score
8
A measure of an organisations or investment's impact on the natural environment, including factors such as carbon emissions, resource usage, and pollution
⚖️
Governance Score
32
An evaluation of an organisations impact on society, focusing on factors such as employee welfare, diversity and inclusion, community engagement, and product safety and quality.
🤓 Advanced information
Technical Info
💰 Price*
$0.06
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in TAM
1
📊 Total Capital Earnings
$23.60
🔃 Average investment frequency
12 weeks
💵 Average investment amount
$1,078
⏰ Last time a customer invested in TAM
2 days
TAM investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100%
100k - 150k
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
100%
35 - 90
🙋 Legal gender of investors
Female
Male
100%
Pearlers who invest in TAM also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
9.33%
📊 Share price
$110.41 AUD
🇦🇺 AUSTRALIA
💸 FINANCIALS
🧱 MATERIALS
⛳️ DIVERSIFIED
📈 HIGH PRICE GROWTH
Actinogen Medical Ltd. is a clinical stage Australian biotechnology company, which focuses on the development of novel treatments or cognitive impairment associated with neurological, psychiatric, and metabolic diseases due to raised cortisol. The company is headquartered in Sydney, New South Wales. The company went IPO on 2007-10-16. The firm is engaged in the development of a therapy for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol. The firm is engaged in the development of its lead compound, Xanamem, as a therapy for Alzheimer’s Disease, Major Depressive Disorder, Fragile X Syndrome, and other neurological diseases where reducing cortisol inside brain cells could have a positive impact. Xanamem’s mechanism of action is to block the production of cortisol inside cells through the inhibition of the 11B-HSD1 enzyme in the brain. Xanamem is designed to get into the brain after it is absorbed in the intestines upon swallowing its capsule. The company has studied 11B-HSD1 inhibition by Xanamem in approximately 300 volunteers and patients. The firm conducts a series of Phase II studies in multiple diseases to further confirm and characterize Xanamem’s therapeutic potential.
🙌 Performance (5Yr p.a)
0.04%
📊 Share price
$0.03 AUD
🧬 BIOTECHNOLOGY
Adairs Ltd. is engaged in retail operations in thef manchester and homewares. The company is headquartered in Melbourne, Victoria. The company went IPO on 2015-06-17. The firm has three vertically integrated brands, Adairs, Mocka, and Focus on Furniture. Its brands sell in-house designed products direct to customers in Australia and New Zealand. Adairs is a specialty omni-channel retailer of home furnishings in Australia and New Zealand with a national footprint of stores across various formats and an online channel. Mocka is a vertically integrated pure-play online home and living products designer and retailer operating in Australia and New Zealand. Mocka sells its own products in the home furniture and decor, kids, and baby categories. Focus on Furniture (Focus) is a vertically integrated omni-channel furniture and bedding retailer offering products through its network of stores in Australia and its online channel.
🙌 Performance (5Yr p.a)
-3.49%
📊 Share price
$2.60 AUD
🛍️ CONSUMER
AFT Pharmaceuticals Ltd. engages in the development, licensing, and distribution of medical and pharmaceutical products. The firm develops, markets, and distributes a portfolio of pharmaceutical products across a range of therapeutic categories, which are distributed across three pharmaceutical distribution channels: over the counter (OTC), prescription and hospital. Its product portfolio comprises both proprietary and in-licensed products, and includes patented, branded, and generic drugs. The firm develops and in-licenses products for sale by sales teams in Australia and New Zealand and in certain Southeast Asian markets, and out-licenses its products to local licensees and distributors in the rest of the world. Its products include A-Scabies, Allersoothe, Allersoothe Elixir, BecloClear, Candaderm, Coco-Scalp, Cromo-Fresh, Fenpaed, Fenpaed Double Strength, Ferro-Sachets, HYLO-FORTE, Itch-Soothe, Kiwisoothe, Lax-Tab, Loraclear, VitA-POS, and others.
🙌 Performance (5Yr p.a)
-10.34%
📊 Share price
$2.30 AUD
📦 LOGISTICS
Accent Group Ltd. operates as an investment holding company, which engages in the retail of performance and lifestyle footwear. The company is headquartered in Richmond, Victoria. The company went IPO on 2004-07-07. The firm operates approximately 903 stores across 18 different retail banners, and distribution rights for 12 international brands across Australia and New Zealand. The firm operates through two segments: Retail and Wholesale. The Retail segment is engaged in selling of footwear and apparel directly to consumers. The Wholesale segment is engaged in selling of footwear and apparel in bulk internally and to other businesses. The Company’s banners and brands include Platypus Shoes, The Athlete’s Foot (TAF), Hype DC, Skechers, Merrell, Vans, Dr. Martens, Saucony, Timberland, HOKA, Superga, Subtype, Stylerunner, Glue Store, Nude Lucy and UGG.
🙌 Performance (5Yr p.a)
-1.83%
📊 Share price
$1.34 AUD
🛍️ CONSUMER
Want more shares? Try these...
🕊️
Social Score
11
An assessment of an organisations management practices, board structure, transparency, and accountability, reflecting its commitment to ethical behavior and responsible decision-making.